Kerman University of Medical Sciences also called KMU, is a university located in Kerman, Iran. KMU is the 8th largest medical university in Iran and the largest university of medical sciences in southeast of the country with about 6000 students and 503 faculties.

During the past decade, Kerman University of Medical Sciences conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kerman University of Medical Sciences" are "Ankylosing Spondylitis" (1 trials), "Hemorrhagic Shock" (1 trials), "IVC Collapsibility Index" (1 trials), "Psoriatic Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Kerman University of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Kerman University of Medical Sciences" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etanercept" (1 trials) and "Measuring IVC collapsibility index by bedside ultrasonography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kerman University of Medical Sciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kerman University of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kerman University of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kerman University of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".